USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

The audit at Indrad plant of the company was carried out by the United
States Food and Drug Administration (USFDA) in April.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-makes-certain-observations-for-torrent-pharmas-indrad-plant/articleshow/69053644.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online